Day: September 19, 2025

// Not for distribution to the United States newswire services or for dissemination in the United States // VANCOUVER, British Columbia, Sept. 19, 2025 (GLOBE NEWSWIRE) — Copper Quest Exploration Inc. (CSE: CQX; FRA: 3MX) (“Copper Quest” or the “Company”) is pleased to announce that it has closed the second and final tranche (the “Second Tranche”) of its previously announced non-brokered private placement (the “Private Placement”) with the issuance of 4,070,534 units (the “Units”, and each, a “Unit”) of the Company at a price of $0.075 per Unit for gross proceeds of $305,290.05. Each Unit consists of one (1) common share of the Company (“Share”) and one (1) Share purchase warrant, whereby each Share purchase warrant (“Warrant”) is convertible into an additional Share (“Warrant Share”) at an exercise price of $0.15 per Warrant Share....

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) — Q-Gold Resources Ltd. (TSXV: QGR) (“Q-Gold” or the “Company”) is pleased to announce that BMO Nesbitt Burns Inc., the agent engaged to assist the Company with its previously announced offering of up to 66,666,667 units (the “Offering”) on a “best efforts” basis, has confirmed that the Offering is fully allocated. For more information about the Offering, please see the Company’s press release dated August 29, 2025, a copy of which is available under the Company’s profile at www.sedarplus.ca. Peter Tagliamonte, chief executive officer and president of the Company, commented: “We are very pleased with the strong response to our financing, which has been fully allocated. We believe that the support...

LUXEMBOURG, Sept. 19, 2025 (GLOBE NEWSWIRE) — Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) (“Tenaris”, or the “Company”) announced that its indirect controlling shareholder San Faustin S.A. and its direct controlling shareholder Techint Holdings S.à r.l. (the “Reporting Persons”) filed earlier today with the SEC an amendment to their Schedule 13D, reporting that, for portfolio-management purposes and in response to Tenaris’s ongoing share repurchase program causing San Faustin’s beneficial ownership interest in Tenaris to passively increase, on September 17, 2025, the board of directors of San Faustin had authorized Techint Holdings to sell a number of its ordinary shares of Tenaris, provided that Techint Holdings’ ownership stake in Tenaris should not fall below 67% of Tenaris’s total outstanding ordinary shares.  The...

Vancouver, British Columbia, Sept. 19, 2025 (GLOBE NEWSWIRE) — Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) announces the grant of long-term equity-based incentive awards under its Share Compensation Plan. The Company has awarded 2,337,500 restricted share units (RSUs) to employees and executives, and 1,750,000 deferred share units (DSUs) to non-executive directors, both based on the 5-day volume weighted average price on the TSX Venture Exchange. The RSUs will vest in equal annual installments over three-years from the grant date. The DSUs will vest upon the departure of the holder from the Company. A copy of the Share Compensation Plan, approved by shareholders at the last annual general meeting, is available on the Company’s website at www.surgecopper.com/investors/agm-materials...

VANCOUVER, British Columbia, Sept. 19, 2025 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company announces the voting results at its annual and special meeting of shareholders held earlier today (the “Meeting”) including an ordinary resolution (the “Resolution”) to approve an alteration to the Company’s authorized share structure and Articles, to include an unlimited number of Preferred Shares, of which an unlimited number of Preferred Shares will be designated as Series 1. The Resolution received greater than 93% of the votes in favor. The Series 1 Preferred Shares include a ten percent annual dividend payable in Common Shares or Preferred Shares at the discretion of the Company’s Board of Directors and are convertible...

NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at Bernstein’s 2nd Annual Healthcare Forum on Tuesday, September 23, 2025 at 2:50 p.m. ET. The webcast will be accessible from Royalty Pharma’s “Events” page at https://www.royaltypharma.com/investors/events/. The webcast will also be archived for a minimum of thirty days. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which...

CARMEL, Ind., Sept. 19, 2025 (GLOBE NEWSWIRE) — MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that it will provide topline results from its Phase 2 clinical trial of potential once-weekly canvuparatide for patients with chronic hypoparathyroidism (HP) and host an investor webcast on Monday, September 22. The Company will host a conference call and webcast at 8 am ET on Monday, September 22 to discuss the results from the Avail™ Phase 2 trial. Those who would like to participate may access the live webcast here or dial 1-877-407-0779 (US) or 1-201-389-0914 (international). The live and archived webcast of the call and slide presentation will...

TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its LaNeo™ MDMA), is pleased to announce that it has filed an amended and restated preliminary short form base shelf prospectus (the “Prospectus”) to provide the Company with the flexibility to take advantage of financing opportunities and favourable market conditions, if and when needed, during the 25-month period that the Prospectus, once made final, remains effective (the “Effective Period”). A copy of the Prospectus may be obtained under the Company’s SEDAR+ profile at www.sedarplus.ca. The Prospectus has been filed in each of the provinces and territories in Canada. The...

TYLER, Texas, Sept. 19, 2025 (GLOBE NEWSWIRE) — Southside Bancshares, Inc. (the “Company”) and Southside Bank (the “Bank”), a subsidiary of the Company, has announced the upcoming retirement of Lee Gibson, Chief Executive Officer (“CEO”) and director of the Company and the Bank, effective December 31, 2025. Mr. Gibson will continue as a director of the Company and the Bank. Succeeding him as CEO upon his retirement is Keith Donahoe, current President of the Company and the Bank, who has over 30 years of banking experience. “It goes without saying that Lee has been a vital part of this organization’s success over the last 40-plus years,” said Jay Shands, Chairman of the Board of Southside Bank and Southside Bancshares, Inc. “Starting his career with Southside in 1984, Lee has had a front row seat to a vibrant and often tempestuous...